|
4-bromo-6-methyl-1-tetrahydropyran-2-yl-5-(trifluoromethyl)indazole
|
B677947-250mg
|
≥97% |
2326524-90-5 |
250mg
|
¥ 1488.9
|
期货,请咨询 |
阿拉丁 |
|
4-bromo-6-methyl-1-tetrahydropyran-2-yl-5-(trifluoromethyl)indazole
|
B677947-1g
|
≥97% |
2326524-90-5 |
1g
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
|
4-bromo-6-methyl-1-tetrahydropyran-2-yl-5-(trifluoromethyl)indazole
|
B677947-10g
|
≥97% |
2326524-90-5 |
10g
|
¥ 16032.9
|
期货,请咨询 |
阿拉丁 |
|
4-bromo-6-methyl-1-tetrahydropyran-2-yl-5-(trifluoromethyl)indazole
|
B677947-100mg
|
≥97% |
2326524-90-5 |
100mg
|
¥ 896.9
|
期货,请咨询 |
阿拉丁 |
|
4-bromo-6-methyl-1-tetrahydropyran-2-yl-5-(trifluoromethyl)indazole
|
B677947-100g
|
≥97% |
2326524-90-5 |
100g
|
¥ 83616.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl N-(5-hydroxy-2-methyl-pentyl)carbamate
|
B677941-500mg
|
≥97% |
1861200-05-6 |
500mg
|
¥ 14560.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl N-(5-hydroxy-2-methyl-pentyl)carbamate
|
B677941-250mg
|
≥97% |
1861200-05-6 |
250mg
|
¥ 10192.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl N-(5-hydroxy-2-methyl-pentyl)carbamate
|
B677941-1g
|
≥97% |
1861200-05-6 |
1g
|
¥ 20800.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl N-(5-hydroxy-2-methyl-pentyl)carbamate
|
B677941-100mg
|
≥97% |
1861200-05-6 |
100mg
|
¥ 6112.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (4R)-4-methyl-2,2-dioxo-oxathiazolidine-3-carboxylate
|
B677938-1g
|
≥97% |
2845995-91-5 |
1g
|
¥ 1424.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (2S)-2-(aminomethyl)azetidine-1-carboxylate
|
B677934-500mg
|
≥97% |
1932391-34-8 |
500mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (2S)-2-(aminomethyl)azetidine-1-carboxylate
|
B677934-250mg
|
≥97% |
1932391-34-8 |
250mg
|
¥ 2880.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (2S)-2-(aminomethyl)azetidine-1-carboxylate
|
B677934-1g
|
≥97% |
1932391-34-8 |
1g
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (2S)-2-(aminomethyl)azetidine-1-carboxylate
|
B677934-100mg
|
≥97% |
1932391-34-8 |
100mg
|
¥ 2160.9
|
期货,请咨询 |
阿拉丁 |
|
(2R)-2-(azetidin-1-ylmethyl)butanoic acid
|
B677930-5g
|
≥97% |
2803376-28-3 |
5g
|
¥ 19776.9
|
期货,请咨询 |
阿拉丁 |
|
(2R)-2-(azetidin-1-ylmethyl)butanoic acid
|
B677930-500mg
|
≥97% |
2803376-28-3 |
500mg
|
¥ 4608.9
|
期货,请咨询 |
阿拉丁 |
|
(2R)-2-(azetidin-1-ylmethyl)butanoic acid
|
B677930-250mg
|
≥97% |
2803376-28-3 |
250mg
|
¥ 3184.9
|
期货,请咨询 |
阿拉丁 |
|
(2R)-2-(azetidin-1-ylmethyl)butanoic acid
|
B677930-1g
|
≥97% |
2803376-28-3 |
1g
|
¥ 6592.9
|
期货,请咨询 |
阿拉丁 |
|
(2R)-2-(azetidin-1-ylmethyl)butanoic acid
|
B677930-100mg
|
≥97% |
2803376-28-3 |
100mg
|
¥ 2384.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (3S,4R)-3-(tert-butoxycarbonylamino)-4-hydroxy-piperidine-1-carboxylate
|
B677912-5g
|
≥97% |
1549812-65-8 |
5g
|
¥ 30288.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (3S,4R)-3-(tert-butoxycarbonylamino)-4-hydroxy-piperidine-1-carboxylate
|
B677912-500mg
|
≥97% |
1549812-65-8 |
500mg
|
¥ 4688.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (3S,4R)-3-(tert-butoxycarbonylamino)-4-hydroxy-piperidine-1-carboxylate
|
B677912-25g
|
≥97% |
1549812-65-8 |
25g
|
¥ 113312.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (3S,4R)-3-(tert-butoxycarbonylamino)-4-hydroxy-piperidine-1-carboxylate
|
B677912-250mg
|
≥97% |
1549812-65-8 |
250mg
|
¥ 2752.9
|
期货,请咨询 |
阿拉丁 |
|
benzyl (3S,4R)-3-(tert-butoxycarbonylamino)-4-hydroxy-piperidine-1-carboxylate
|
B677912-1g
|
≥97% |
1549812-65-8 |
1g
|
¥ 7968.9
|
期货,请咨询 |
阿拉丁 |